Tag: Global Health

 

“Google For Doctors”: How the G20 and World Bank Can Help Tackle Antibiotic Resistance – Podcast with Lord Jim O’Neill

Blog Post

The economist who coined the term "BRICS" thinks he has a hot investing tip. In this edition of the CGD podcast, Lord Jim O’Neill of Gatley, a minister in the UK Treasury, tells me that if it costs the world $40 billion over ten years to stop 10 million deaths and “stop the loss of $100 trillion of global GDP, that’s something like a two-and-a-half-thousand percent return.... That seems to me like a pretty good investment.”

Tobacco: Control or Eradicate? – Podcast with David Sweanor and Bill Savedoff

Blog Post

A billion premature deaths this century—that’s the estimated toll of smoking. As 80% of the world’s smokers live in low- to middle-income countries, that’s a huge problem for the developing world. So what’s the solution? You’ve heard before from CGD senior fellow Bill Savedoff that increasing tobacco taxes can actually help turn people away from nicotine; on this week’s podcast, you’ll hear another idea. 

Tobacco Control or Eradication: Are ENDS part of an endgame?

Blog Post

Is the tobacco epidemic more like smallpox or HIV? It’s an important question. If it is like smallpox, then we can pursue strategies to eradicate tobacco as a risk to human health. However, if it is like HIV, we instead need to be thinking in terms of controlling and managing the epidemic.

Failing to Deliver on Family Planning? Funding in Crisis

Blog Post

More than 5000 international personalities and technical experts are wrapping up the Women Deliver Conference in Copenhagen this week. The topic: how to empower women, reduce gender inequality, and improve the sexual and reproductive health of women and girls in low- and middle-income countries. Family planning and reproductive health commodities are central to this broader agenda. Yet according to our onsite sources, the conference has barely (if at all) remarked on the funding cuts that UNFPA, the United Nations Population Fund, has experienced since last year.

CGD at Women Deliver 2016

Blog Post

Five thousand researchers, practitioners, advocates and others are descending on Copenhagen for Women Deliver, the largest conference focused on the health, rights, and well-being of women and girls. Much of what will be discussed aligns with CGD’s own work through our global health policy and gender and development programs, so we’re pleased to be attending and below, we’re pleased to share with you a few of the conference areas where we can add our voice. 

Next Up on the Universal Health Coverage Agenda: Value for Money

Blog Post

At the World Bank’s Annual Universal Health Coverage (UHC) Financing Forum this year, I took part in a mock competition to help determine the topic of next year’s forum. I was up against Larry Gostin, who argued that the 2017 forum should focus on equity and human rights, and Sara Bennett, who made the case for it to be the political economy. My pitch was for the forum to focus on efficiency—or value for money—in UHC reforms, and here’s why.

What About a Global Treaty to Feed Pigs Yogurt Rather Than Drugs?

Blog Post

Most antibiotics around the world today are fed to farm animals to promote growth and prevent diseases fostered by crowded conditions on factory farms. There is an urgent need to find alternatives to keep animals healthy, and preserve crucial antibiotics for human health. One way to do that would be to create an international treaty not to use antibiotics in livestock feed — and probiotics, like those found in yogurt, may be a stepping stone toward that goal. 

Confronting Antimicrobial Resistance: Can We Get to Collective Action?

Blog Post

Imagine if a small cut could evolve into a lengthy hospital stay, or worse; if doctors refused to perform surgery or transplants due to prohibitive risk during recovery; and if our collective gains against the world’s biggest infectious killers—HIV, malaria, tuberculosis, sexually transmitted infections, pneumonia, and more—slowed, stalled, and reversed. These nightmare scenarios could become the new global reality if common pathogens evolve to withstand and survive treatment with antimicrobial drugs, a phenomenon known as antimicrobial resistance (AMR).

Pages

Experts